HUTCHMED (China) Ltd
HCM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001648257
No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.
Other share classesHMDCF
Q4 2023 vs. Q3 2023
How the institutions holding HUTCHMED (China) Ltd changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 65 | 71 | +6 |
| Shares | 23.1M | 15.4M | −7.61M (−33.0%) |
| Value | $391.0M | $279.1M | −$111.9M (−28.6%) |
New holders (7)
Institutions that held HUTCHMED (China) Ltd at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cubist Systematic Strategies, LLC | 22,436 | $406.3K | 0.01% |
| Envestnet Asset Management Inc | 15,142 | $274.2K | 0.00% |
| LMR Partners LLP | 12,473 | $225.9K | 0.01% |
| SEI Investments Co | 10,872 | $196.9K | 0.00% |
| Arlington Trust Co LLC | 86 | $1.56K | 0.00% |
| Ronald Blue Trust, Inc. | 63 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 4 | $72 | 0.00% |
Sold out (1)
Institutions that held HUTCHMED (China) Ltd at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Quantbot Technologies LP | 700 | $11.9K |